Investor Updates News 24 September 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025

Telomir Pharmaceuticals (NASDAQ: TELO) shares react to new preclinical leukemia data and a director resignation on November 21, 2025. Here’s what today’s Telomir-1 news means for TELO stock and investors. What happened to Telomir Pharmaceuticals (TELO) today? On Friday, November

21 November 2025

ADP Stock News Today (Nov. 20, 2025): New Global WorkForce Suite, London Investor Conference & Fresh Earnings Outlook

Automatic Data Processing, Inc. (NASDAQ: ADP) is back in the headlines today with a major product launch, a new investor conference appearance, and updated analyst expectations. ADP launches unified global WorkForce Suite across its HCM platforms The biggest ADP story

20 November 2025

Earnings Reports · Financial Technology · Global Business · Investor Updates · NASDAQ:ADP · Stock Market News

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Today (Nov 18, 2025): CSCO Edges Lower as Investors Eye CFO’s Wells Fargo TMT Remarks and Fresh ‘Stargate UAE’ Developments

Byline: Markets | Cisco Systems (NASDAQ: CSCO) | November 18, 2025 Key takeaways Live price and market move Cisco Systems’ stock slipped to $76.65 (-1.45%) by 16:11 UTC, with trading so far between $76.47 and $78.19. The dip follows last

18 November 2025

Cisco News · Financial Analysis · Investor Updates · Stock Market · Technology Sector

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti (RGTI) Q3 2025: Revenue Miss, EPS Beat, Cash Near $600M; New Orders & AFRL Contract as Investors Track Today’s Call (11/11/2025)

Published: November 11, 2025 Rigetti Computing reported third‑quarter 2025 results with revenue below Wall Street expectations but a narrower‑than‑forecast loss, while highlighting fresh system orders, a major U.S. Air Force contract and a more ambitious technology roadmap. Shares slipped following

11 November 2025

Earnings Reports · Financial News · Investor Updates · NASDAQ:RGTI · Quantum Computing · Rigetti Computing

Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Marriott Ends Sonder Partnership After ‘Default,’ Cuts 2025 Net Rooms Growth Outlook to ~4.5% — What Travelers & Investors Need to Know (Nov 10, 2025)

Published: November 10, 2025 Summary: Marriott International has terminated its licensing agreement with short‑term‑rental operator Sonder after a “default,” removed Sonder listings from Marriott Bonvoy channels, and trimmed its 2025 net rooms growth outlook to ~4.5%. Here’s the latest on

10 November 2025

Business Strategy · Hospitality · Hotel Industry · Investor Updates · NASDAQ:MAR · Travel News

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and

6 November 2025

Company News · Earnings Reports · Financial Analysis · Investor Updates · NYSE:VST · Stock Market

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock and Company Update as of September 24, 2025 Stock Performance & Technical Analysis Cidara’s stock has been on a tear in 2025, delivering triple-digit percentage gains. Year-to-date, CDTX has risen about +173% as of late September investing.com, driven by

24 September 2025

Biotech · Drug Development · Investor Updates · NASDAQ:CDTX · Pharma News · Stock Market

Investor Updates News 24 September 2025 - 21 November 2025